UK markets open in 1 hour 59 minutes

Molecular Partners AG (MOLN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.66-0.05 (-0.82%)
At close: 12:19PM EST
Show:
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
188,638
9,330
9,344
20,383
10,355
Cost of revenue
-
-
-
-
15,602
Gross profit
-
-
-
-
-5,247
Operating expenses
Research development
50,994
55,718
56,075
43,498
38,203
Selling general and administrative
21,386
16,906
11,027
13,164
9,462
Total operating expenses
72,859
72,749
67,670
57,043
47,765
Operating income or loss
115,779
-63,419
-58,326
-36,660
-37,410
Interest expense
701
548
271
27
-
Total other income/expenses net
1,769
92
-4,513
-1,110
-218
Income before tax
117,376
-63,783
-62,775
-36,271
-37,036
Income tax expense
2
2
-11
17
0
Income from continuing operations
117,374
-63,785
-62,764
-36,288
-37,036
Net income
117,374
-63,785
-62,764
-36,288
-37,036
Net income available to common shareholders
117,374
-63,785
-62,764
-36,288
-37,036
Basic EPS
-
-2.06
-2.51
-1.69
-1.75
Diluted EPS
-
-2.06
-2.51
-1.69
-1.75
Basic average shares
-
31,005
25,001
21,413
21,168
Diluted average shares
-
31,005
25,001
21,413
21,168
EBITDA
-
-60,670
-59,617
-33,775
-36,486